Blueprint Medicines shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $17M | 175k | 94.86 |
| 2023-12-31 | $25M | 270k | 92.24 |
| 2023-09-30 | $469k | 9.3k | 50.22 |
| 2023-03-31 | $2.2M | 50k | 44.99 |
| 2022-12-31 | $1.6M | 36k | 43.80 |
| 2022-09-30 | $3.9M | 59k | 65.89 |
| 2022-06-30 | $23M | 459k | 50.51 |
| 2022-03-31 | $18M | 275k | 63.88 |
| 2021-12-31 | $6.2M | 58k | 107.11 |
| 2021-09-30 | $25M | 246k | 102.81 |
| 2021-06-30 | $23M | 262k | 87.96 |
| 2020-09-30 | $8.0M | 86k | 92.70 |
| 2020-03-31 | $561k | 9.6k | 58.44 |
| 2019-12-31 | $239k | 3.0k | 79.99 |
| 2019-03-31 | $1.4M | 18k | 80.07 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management